Dr. Jeanne Drisko to BBC News:
"Patients are looking for safe and low-cost choices in their management of cancer. Intravenous vitamin C has that potential based on our basic science research and early clinical data."
Qi Chen, lead author of the new study wrote:
"Because vitamin C has no patent potential, its development will not be supported by pharmaceutical companies. We believe that the time has arrived for research agencies to vigorously support thoughtful and meticulous clinical trials with intravenous vitamin C."...